Appointed
Dwight Gibson
Director
AMRZ ·
Amrize Ltd
Dwight Gibson Director
Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 4201–4250 of 76264
Dwight Gibson Director
Denise R. Singleton Chief Legal Officer and Corporate Secretary
Stephen Clark Chief People Officer
Theresa Drew Director
Roald Brouwer Chief Technology Officer
Samuel J. Poletti Chief Strategy and M&A Officer
Michael E. McKelvy Director
Jake Gosa President, Building Envelope
Effective as of the consummation of the Spin-off, each of Samuel Poletti, Lukas Studer and Markus Leo Unternährer resigned from his position as a director on the Company Board.
Effective as of the consummation of the Spin-off, each of Samuel Poletti, Lukas Studer and Markus Leo Unternährer resigned from his position as a director on the Company Board.
Effective as of the consummation of the Spin-off, each of Samuel Poletti, Lukas Studer and Markus Leo Unternährer resigned from his position as a director on the Company Board.
Katja Roth Pellanda Director
Ian Johnston* Chief Financial Officer
Robert S. Rivkin Director
Mario Gross Chief Supply Chain Officer
Nollaig Forrest* Chief Marketing and Corporate Affairs Officer
Holli Ladhani Director
Nicholas Gangestad Director
On June 19, 2025, the board of directors (the “Board”) of The Greenbrier Companies, Inc. (the “Company”) increased the size of the Board from eight to ten members and appointed Stevan Bobb and Jeffrey Songer to the newly created board seats, to serve on the Board beginning on June 19, 2025, as a Class III and Class I director, respectively.
On June 19, 2025, the board of directors (the “Board”) of The Greenbrier Companies, Inc. (the “Company”) increased the size of the Board from eight to ten members and appointed Stevan Bobb and Jeffrey Songer to the newly created board seats, to serve on the Board beginning on June 19, 2025, as a Class III and Class I director, respectively.
On June 20, 2025, Matthew Doctor, the President and Chief Executive Officer and a member of the Board of Directors (the “Board”) of Regis Corporation (the “Company”) notified the Board that he would resign his positions, effective June 30, 2025.
the Board appointed Jim Lain, the Company’s Executive Vice President, Brand Operations - Supercuts and Cost Cutters, to serve as Interim President and Chief Executive Officer, effective July 1, 2025
On June 20, 2025, the board of directors (the “Board”) of Candel Therapeutics, Inc. (the “Company”) unanimously appointed Charles Schoch as the Company’s Chief Financial Officer, effective June 20, 2025
On June 19, 2025, Brett White notified the board of directors (the “Board”) of Cushman & Wakefield plc (the “Company”) of his decision to resign from the Board, effective July 31, 2025.
appointed each of Susan Daimler and Timothy Wennes to serve as a director on the Board effective as of August 1, 2025
In addition, Mr. Plavin will become the Chairman of the Board effective October 1, 2025.
appointed each of Susan Daimler and Timothy Wennes to serve as a director on the Board effective as of August 1, 2025
On June 17, 2025, Travis McCourt, and on June 18, 2025, Ashley L. Marshall and Alejandro Tani, delivered written notice of resignation from the board of directors (the “Board”) of Stran & Company, Inc. (the “Company”), effective immediately.
On June 17, 2025, Travis McCourt, and on June 18, 2025, Ashley L. Marshall and Alejandro Tani, delivered written notice of resignation from the board of directors (the “Board”) of Stran & Company, Inc. (the “Company”), effective immediately.
On June 17, 2025, Travis McCourt, and on June 18, 2025, Ashley L. Marshall and Alejandro Tani, delivered written notice of resignation from the board of directors (the “Board”) of Stran & Company, Inc. (the “Company”), effective immediately.
On June 20, 2025, the Board elected each of Mark Charles Adams and Sarah L. Cummins to the Board, filling two of the vacancies on the Board resulting from the resignations of Ms. Marshall, Mr. McCourt, and Mr. Tani.
On June 20, 2025, the Board elected each of Mark Charles Adams and Sarah L. Cummins to the Board, filling two of the vacancies on the Board resulting from the resignations of Ms. Marshall, Mr. McCourt, and Mr. Tani.
On June 19, 2025, Leung Tsz Kan was appointed to the Board of Directors (the “Board”) of Linkhome Holdings Inc. (the “Company”).
appointed Mr. Jian Huang, a current member of the Board and the Company’s Executive Vice President, as Co-Chief Executive Officer of the Company, effective immediately.
On June 16, 2025, the Company received notices of resignation from Annie Pratt, resigning from her role as President of the Company and from the Board, and Sarah Wyant, resigning from her role as Chief Financial Officer of the Company, each effective as of June 16, 2025.
On June 16, 2025, the Company received notices of resignation from Annie Pratt, resigning from her role as President of the Company and from the Board, and Sarah Wyant, resigning from her role as Chief Financial Officer of the Company, each effective as of June 16, 2025.
On June 23, 2025, Jessica Billingsley resigned from the Board, effective as of June 23, 2025.
On June 18, 2025, Nancy H. Agee, Ajay Gupta, James J. Kilroy, Peter F. Lyle, Sr., and Christann M. Vasquez retired from the Board of Directors (the “Board”) of Healthcare Realty Trust Incorporated (the “Company”).
On June 18, 2025, Nancy H. Agee, Ajay Gupta, James J. Kilroy, Peter F. Lyle, Sr., and Christann M. Vasquez retired from the Board of Directors (the “Board”) of Healthcare Realty Trust Incorporated (the “Company”).
On June 18, 2025, Nancy H. Agee, Ajay Gupta, James J. Kilroy, Peter F. Lyle, Sr., and Christann M. Vasquez retired from the Board of Directors (the “Board”) of Healthcare Realty Trust Incorporated (the “Company”).
On June 18, 2025, Nancy H. Agee, Ajay Gupta, James J. Kilroy, Peter F. Lyle, Sr., and Christann M. Vasquez retired from the Board of Directors (the “Board”) of Healthcare Realty Trust Incorporated (the “Company”).
On June 18, 2025, Nancy H. Agee, Ajay Gupta, James J. Kilroy, Peter F. Lyle, Sr., and Christann M. Vasquez retired from the Board of Directors (the “Board”) of Healthcare Realty Trust Incorporated (the “Company”).
On June 13, 2025 , the Company’s Board of Directors appointed Kelly Brown, President of the Company’s Property Management Division, and Keith Schroeder, the Company’s current Chief Financial Officer and Secretary, to each act as interim Co-Chief Executive Officers effective as of July 1, 2025, and their focus will be on growing the Company’s Property Management Division and right sizing the Company and its subsidiaries.
On June 13, 2025 , the Company’s Board of Directors appointed Kelly Brown, President of the Company’s Property Management Division, and Keith Schroeder, the Company’s current Chief Financial Officer and Secretary, to each act as interim Co-Chief Executive Officers effective as of July 1, 2025, and their focus will be on growing the Company’s Property Management Division and right sizing the Company and its subsidiaries.
On June 13, 2025, as a result of the transaction described above, Beth Garvey, the Company’s Chair, President and Chief Executive Officer, resigned from her director and officer positions within the Company and its subsidiaries effective as of July 1, 2025 to pursue other interests.
On June 18, 2025, the Board of Directors (“the Board”) of Skkynet Cloud Systems, Inc. (“the Company”) appointed Mr. Gary Tillery to serve as a director of the Company, effective immediately.
Concurrent with the new appointment, Mr. Su-Leng Tan Lee ceased his role as acting Chief Financial Officer and Principal Financial Officer of the Company.
On June 17, 2025, the Board of Directors of BioNexus Gene Lab Corp. (the “Company”) appointed Ms. Chong Set Fui (Angeline) as the Company’s Chief Financial Officer and Principal Financial Officer, effective immediately.
Mr. Saadati will resign from the Company’s Board of Directors (the “ Board ”), effective upon consummation of the Stock Repurchase.
On June 18, 2025, the Board of Directors (Board) of Medtronic plc (Company) increased the size of the Board from 10 to 11 and appointed Dr. Joon Lee as a new director of the Company, in each case effective as of June 18, 2025.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.